OR WAIT null SECS
December 10, 2020
Evonik offers lipid nanoparticles for gene-based drug development and manufacturing.
December 09, 2020
The company has received $500 million in funding from Sino Biopharmaceutical for further development, capacity expansion, and manufacturing of CoronaVac, its COVID-19 vaccine candidate.
CDMO HALIX will manufacture the drug substance for AstraZeneca’s COVID-19 vaccine candidate, AZD1222, at commercial scale at its cGMP facility in the Netherlands.
December 08, 2020
The company will expand its micronization abilities for highly potent drug compounds through this investment.
A development agreement will study inhaled formulations of cannabinoid-based drug product for central nervous system diseases.
December 03, 2020
Janssen announces rolling submissions for its COVID-19 vaccine with Health Canada and EMA.
Operator, caregiver, and patient safety are at the forefront when selecting the best options and dosage forms.
Study results indicate that fatty alcohols may plausibly enhance the skin permeation of clotrimazole.
The COVID-19 pandemic has accelerated the need for modular designs to rapidly expand vaccine production capacity.
December 02, 2020
The investment will expand and upgrade manufacturing capacity and technology for pre-fillable syringes and will also includes a new manufacturing facility in Europe.